scispace - formally typeset
Book ChapterDOI

Unified Parkinson's Disease Rating Scale

Victor R. Preedy, +1 more
- pp 4343-4343
About
The article was published on 2010-01-01. It has received 691 citations till now. The article focuses on the topics: Unified Parkinson's disease rating scale.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Christopher G. Goetz, +87 more
- 15 Nov 2008 - 
TL;DR: The combined clinimetric results of this study support the validity of the MDS‐UPDRS for rating PD.
Journal ArticleDOI

Colonic inflammation in Parkinson's disease.

TL;DR: Findings provide evidence that enteric inflammation occurs in Parkinson's disease and further reinforce the role of peripheral inflammation in the initiation and/or the progression of the disease.
Journal ArticleDOI

The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale

TL;DR: In this paper, a cross-sectional analysis of the CIDs for UPDRS total and motor scores was performed on patients with Parkinson disease (PD) using distribution-and anchor-based approaches based on the following external standards: disability (10% on the Schwab and England Activities of Daily Living Scale), disease stage (1 stage on the Hoehn and Yahr Scale), and quality of life (1 SD on the 12-Item Short Form Health Survey).
References
More filters
Journal ArticleDOI

Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited.

TL;DR: This study suggests that memory impairment in drug naïve early PD to a large degree is a deficit of learning/ encoding and not of retention or retrieval, an implication is that the retrieval deficit hypothesis should be moderated in its general form.
Journal ArticleDOI

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders

TL;DR: Level of inflammatory biomarkers in cerebrospinal fluid found in PD and atypical parkinsonian disorders compared with neurologically healthy controls correlated with more severe disease regarding motor symptoms and cognitive impairment in PD, indicating an association between inflammation and more aggressive disease course.

Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease

TL;DR: In Parkinson's disease, finger tap pattern was compatible with criteria-defined bradykinesia, characterized by slowness with progressive reduction in amplitude and speed and increased variability in speed throughout the tap trial and in progressive supranuclear palsy, the mean amplitude was not correlated with disease duration or other clinimetric scores.
Journal ArticleDOI

Effectiveness of intensive inpatient rehabilitation treatment on disease progression in parkinsonian patients: a randomized controlled trial with 1-year follow-up.

TL;DR: It is suggested that the natural worsening of symptoms associated with PD can be effectively counteracted by a properly designed intensive rehabilitation treatment, and a second rehabilitation cycle administered after 1 year was as effective as the first treatment.
Journal ArticleDOI

Home-based treadmill training for individuals with Parkinson’s disease: a randomized controlled pilot trial

TL;DR: Semi-supervised home-based treadmill training is a feasible and safe form of exercise for cognitively intact people with mild Parkinson’s disease and in quality of life at six weeks follow-up testing.